Technology, Product and RNA Production Partnering

Partnering is a key component of our corporate strategy. See our current strategic partnerships. eTheRNA is exploring innovative ideas – at all stages of development. eTheRNA focuses on maximizing the value of its mRNA platforms via three routes:

Technology Partnering
eTheRNA intends to build high-value strategic collaborations for exploring the benefits of the its various platform technologies in various disease areas.





Product
Partnering
eTheRNA seeks collaborative partnerships with pharma companies that enable us to develop - and ultimately also to commercialize - differentiated mRNA based immunotherapies on either a risk-sharing or out-licensing basis.


mRNA Production Partnering
eTheRNA operates a cGMP accredited mRNA production facility in Niel, Belgium and currently focusses on producing mRNA-constructs exclusively for its own development plans. However as the clinical development program advances, the Company has the option to expand capacity and explore strategic partnerships.